Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity.

The TSOD mouse has been established as an inbred strain with spontaneous development of diabetes mellitus as the first clinical signs of diabetes. Polydipsia and polyuria are observed at about 2 months old only in male mice, after which hyperglycemia and hyperinsulinemia are detected. Following these symptoms obesity gradually develops until about 12 months old. In histopathological examination of the pancreas, severe hypertrophy of pancreatic islets was observed due to proliferation and swelling of B cells. In the kidney, thickening of the basement membrane in glomeruli and an increase of the mesangial area were observed at 18 months old. Motor neuropathy in TSOD mice began to appear at 14 months old and most male mice at 17 months old showed weakness of front and hind paws caused by neuron degeneration in the peripheral nerve. In sensory neuropathy, the threshold in the tail pressure test decreased significantly at 12 months old. Light microscopic and electron microscopic examination of sciatic nerves showed a decrease in the density of nerve fibers by the endoneural fibrosis and loss of these fibers. Degenerative changes of myelinated fibers, separation of myelin sheaths with intralamellar edema and remyelination were frequently observed. In the severely affected nerve fibers, the lamellar structure was completely destroyed and macrophages migrated around the myelin sheath or invaded the intramyelin space. Considering these findings similar to non-insulin dependent diabetes mellitus (NIDDM) in humans, the TSOD mouse should be a useful model for the pathogenic study of diabetic complications, especially of peripheral neuropathy.

[1]  A. Lusis,et al.  BSB: a new mouse model of multigenic obesity. , 1993, Obesity research.

[2]  A. Eschalier,et al.  Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain , 1993, Pain.

[3]  W. Suzuki,et al.  A new mouse model of spontaneous diabetes derived from ddY strain. , 1999, Experimental animals.

[4]  A. Messing,et al.  Peripheral Neuropathy Associated with Functional Islet Cell Adenomas in SV40 Transgenic Mice , 1989, Journal of neuropathology and experimental neurology.

[5]  C. Figueroa,et al.  Pancreatic islet hypertrophy in spontaneous maturity onset obese-diabetic CBA/Ca mice. , 1994, The International journal of biochemistry.

[6]  P. Taberner,et al.  Characterization of the spontaneous diabetes obesity syndrome in mature male CBA/Ca mice , 1989, Pharmacology Biochemistry and Behavior.

[7]  P. Dyck,et al.  Spatial Distribution of Fiber Degeneration in Acute Hypoglycemic Neuropathy in Rat , 1991, Journal of neuropathology and experimental neurology.

[8]  Y. Seino,et al.  Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes. , 2001, European journal of endocrinology.

[9]  A. Michael,et al.  35S-Glycosaminoglycan and 35S-Glycopeptide Metabolism by Diabetic Glomeruli and Aorta , 1982, Diabetes.

[10]  I. Narama,et al.  Peripheral neuropathy in the spontaneously diabetic WBN/Kob rat , 1996, Acta Neuropathologica.

[11]  S. Yagihashi,et al.  Diabetic autonomic neuropathy in the BB rat. Ultrastructural and morphometric changes in sympathetic nerves. , 1985, Diabetes.

[12]  G. Mcclearn,et al.  Central and Peripheral Nervous System Complications , 1982, Diabetes.

[13]  D. Cox,et al.  Effect of hyperglycemia on pain threshold in alloxan-diabetic rats , 1990, Pain.

[14]  S. Yagihashi,et al.  Diabetic autonomic neuropathy. The distribution of structural changes in sympathetic nerves of the BB rat. , 1985, The American journal of pathology.

[15]  S. Yagihashi,et al.  Diabetic Autonomic Neuropathy in the BB rat: Ultrastructural and Morphometric Changes in Sympathetic Nerves , 1985, Diabetes.

[16]  H. Makino,et al.  Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. , 1995, Kidney international.

[17]  P. Thomas,et al.  The polyneuropathy of chronic renal failure. , 1971, Brain : a journal of neurology.

[18]  A. Wein,et al.  Length-tension relationship of urinary bladder strips from streptozotocin-diabetic rats. , 1990, Pharmacology.

[19]  A. Evan,et al.  Abnormalities in pelvic visceral nerves. A basis for neurogenic bladder in the diabetic Chinese hamster. , 1977, Investigative urology.

[20]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[21]  E. Shafrir,et al.  Animal models of non-insulin-dependent diabetes. , 1992, Diabetes/metabolism reviews.

[22]  P K Thomas,et al.  Age changes in the tibial and plantar nerves of the rat. , 1980, Journal of anatomy.

[23]  B. Wyse,et al.  Diabetes in the KK mouse , 1970, Diabetologia.

[24]  C. Jf,et al.  [Diabetic autonomic neuropathy]. , 1989, Atencion primaria.

[25]  D. Greene,et al.  Diabetic and hypoglycemic neuropathy--a comparison in the BB rat. , 1989, Diabetes research and clinical practice.

[26]  功 奈良間 Peripheral motor neuropathy in spontaneously diabetic WBN/Kob rats : a morphometric and electron microscopic study , 1989 .

[27]  W. C. Groat,et al.  Effects of streptozotocin-induced diabetes on bladder function in the rat. , 1990, The Journal of urology.

[28]  H. Kuwano,et al.  Genetic analysis of obese diabetes in the TSOD mouse. , 1999, Diabetes.

[29]  J. Comstock,et al.  Diabetic Autonomic Neuropathy , 2002 .

[30]  R. Wada,et al.  Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[31]  I. Narama,et al.  A new diabetic strain of rat (WBN/Kob) , 1985, Laboratory animals.

[32]  P. K. Thomas,et al.  Changes with age in the peripheral nerves of the rat , 2004, Acta Neuropathologica.

[33]  A. F. Sima,et al.  Pathological Definition and Evaluation of Diabetic Neuropathy and Clinical Correlations , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[34]  S. Yagihashi,et al.  Pathology and pathogenetic mechanisms of diabetic neuropathy. , 1995, Diabetes/metabolism reviews.

[35]  T. Miyazaki,et al.  Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. , 1997, The Journal of clinical investigation.

[36]  T. Ogihara,et al.  The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity , 1995, Diabetologia.